89bio(ETNB) - 2024 Q4 - Annual Results

Financial Position - As of December 31, 2024, the company expects to report approximately $440 million in cash, cash equivalents, and marketable securities[6] - The financial results for the year ended December 31, 2024, are still pending finalization and auditing[6] - The company emphasizes that the preliminary financial information is subject to change and has not been audited[6] Forward-Looking Statements - Forward-looking statements regarding expected financial results are based on current estimates and assumptions, which may be subject to various risks and uncertainties[7] - The company claims protection under the Safe Harbor provisions for forward-looking statements as per the Private Securities Litigation Reform Act of 1995[7]